IBC ADVANCED ALLOYS CORP (IB.CA) Fundamental Analysis & Valuation

TSX-V:IB • CA44923T8683

0.2 CAD
0 (0%)
Last: Mar 6, 2026, 07:00 PM

This IB.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

IB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 817 industry peers in the Metals & Mining industry. Both the profitability and financial health of IB have multiple concerns. IB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. IB.CA Profitability Analysis

1.1 Basic Checks

  • In the past year IB has reported negative net income.
  • IB had a positive operating cash flow in the past year.
  • IB had negative earnings in 4 of the past 5 years.
  • IB had a positive operating cash flow in 4 of the past 5 years.
IB.CA Yearly Net Income VS EBIT VS OCF VS FCFIB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M

1.2 Ratios

  • IB has a Return On Assets of -14.91%. This is comparable to the rest of the industry: IB outperforms 57.23% of its industry peers.
  • IB has a Return On Equity of -188.07%. This is in the lower half of the industry: IB underperforms 68.87% of its industry peers.
Industry RankSector Rank
ROA -14.91%
ROE -188.07%
ROIC N/A
ROA(3y)-10.18%
ROA(5y)-8.13%
ROE(3y)-108.09%
ROE(5y)-72.71%
ROIC(3y)N/A
ROIC(5y)N/A
IB.CA Yearly ROA, ROE, ROICIB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

1.3 Margins

  • Looking at the Gross Margin, with a value of 20.21%, IB belongs to the top of the industry, outperforming 88.48% of the companies in the same industry.
  • IB's Gross Margin has improved in the last couple of years.
  • IB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y7.13%
IB.CA Yearly Profit, Operating, Gross MarginsIB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1

2. IB.CA Health Analysis

2.1 Basic Checks

  • IB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IB has more shares outstanding
  • Compared to 5 years ago, IB has more shares outstanding
  • The debt/assets ratio for IB is higher compared to a year ago.
IB.CA Yearly Shares OutstandingIB.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
IB.CA Yearly Total Debt VS Total AssetsIB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

2.2 Solvency

  • IB has an Altman-Z score of -3.41. This is a bad value and indicates that IB is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -3.41, IB is not doing good in the industry: 66.18% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of IB is 13.15, which is on the high side as it means it would take IB, 13.15 years of fcf income to pay off all of its debts.
  • IB has a Debt to FCF ratio of 13.15. This is amongst the best in the industry. IB outperforms 89.71% of its industry peers.
  • A Debt/Equity ratio of 6.11 is on the high side and indicates that IB has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 6.11, IB is doing worse than 75.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 6.11
Debt/FCF 13.15
Altman-Z -3.41
ROIC/WACCN/A
WACC11.17%
IB.CA Yearly LT Debt VS Equity VS FCFIB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

2.3 Liquidity

  • A Current Ratio of 0.62 indicates that IB may have some problems paying its short term obligations.
  • With a Current ratio value of 0.62, IB is not doing good in the industry: 68.14% of the companies in the same industry are doing better.
  • IB has a Quick Ratio of 0.62. This is a bad value and indicates that IB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of IB (0.17) is worse than 78.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.17
IB.CA Yearly Current Assets VS Current LiabilitesIB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

0

3. IB.CA Growth Analysis

3.1 Past

  • IB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -544.83%.
  • IB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -58.06%.
  • The Revenue has been decreasing by -3.43% on average over the past years.
EPS 1Y (TTM)-544.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-58.06%
Revenue growth 3Y-12.93%
Revenue growth 5Y-3.43%
Sales Q2Q%-14.88%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IB.CA Yearly Revenue VS EstimatesIB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

2

4. IB.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • IB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IB.CA Price Earnings VS Forward Price EarningsIB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IB is valued cheaper than 88.97% of the companies in the same industry.
  • IB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IB is cheaper than 97.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.6
EV/EBITDA 79.22
IB.CA Per share dataIB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. IB.CA Dividend Analysis

5.1 Amount

  • No dividends for IB!.
Industry RankSector Rank
Dividend Yield 0%

IB.CA Fundamentals: All Metrics, Ratios and Statistics

IBC ADVANCED ALLOYS CORP

TSX-V:IB (3/6/2026, 7:00:00 PM)

0.2

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-27
Earnings (Next)05-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners27.35%
Ins Owner ChangeN/A
Market Cap23.05M
Revenue(TTM)17.04M
Net Income(TTM)-2.90M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.99
P/FCF 16.6
P/OCF 13.15
P/B 10.97
P/tB 10.97
EV/EBITDA 79.22
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY6.02%
OCF(TTM)0.02
OCFY7.61%
SpS0.2
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.91%
ROE -188.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.21%
FCFM 5.98%
ROA(3y)-10.18%
ROA(5y)-8.13%
ROE(3y)-108.09%
ROE(5y)-72.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y7.13%
F-Score2
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 6.11
Debt/FCF 13.15
Debt/EBITDA 29.79
Cap/Depr 41.74%
Cap/Sales 1.57%
Interest Coverage N/A
Cash Conversion 407.28%
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.17
Altman-Z -3.41
F-Score2
WACC11.17%
ROIC/WACCN/A
Cap/Depr(3y)45.53%
Cap/Depr(5y)120.38%
Cap/Sales(3y)1.72%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-544.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-58.06%
Revenue growth 3Y-12.93%
Revenue growth 5Y-3.43%
Sales Q2Q%-14.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-109.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y168.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y231.06%
OCF growth 3Y-14.83%
OCF growth 5YN/A

IBC ADVANCED ALLOYS CORP / IB.CA FAQ

Can you provide the ChartMill fundamental rating for IBC ADVANCED ALLOYS CORP?

ChartMill assigns a fundamental rating of 1 / 10 to IB.CA.


What is the valuation status of IBC ADVANCED ALLOYS CORP (IB.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to IBC ADVANCED ALLOYS CORP (IB.CA). This can be considered as Overvalued.


How profitable is IBC ADVANCED ALLOYS CORP (IB.CA) stock?

IBC ADVANCED ALLOYS CORP (IB.CA) has a profitability rating of 2 / 10.